XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Collaborations and Other Arrangements (Tables)
 3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of significant milestones and revenue recognized The table below summarizes the net milestones capitalized with respect to the Jardiance and Trajenta families of products and the net milestones deferred with respect to the Basaglar product family as of March 31, 2023 and December 31, 2022:
Net Milestones Capitalized (Deferred)(1)
March 31, 2023December 31, 2022
Jardiance$111.2 $116.2 
Trajenta57.3 63.5 
Basaglar(126.0)(130.6)
(1) This represents the amounts that have been capitalized (deferred) from the start of this collaboration through the end of the reporting period, net of amount amortized.
The following table summarizes our collaboration and other revenue recognized with respect to the Jardiance and Trajenta families of products and net product revenue recognized with respect to the Basaglar product family:
Three Months Ended March 31,
20232022
Jardiance$577.5 $419.4 
Basaglar209.3 191.5 
Trajenta85.8 92.0 
The following table summarizes our net product revenue recognized with respect to Olumiant:
Three Months Ended March 31,
20232022
Olumiant$228.9 $255.6